GRAIL, LLC

Galleri Test

Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care.

We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges.

GRAIL is headquartered in Menlo Park, California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. 

For more information, please visit grail.com.

Community Guidelines: https://bit.ly/3xigb24 

6 Dimensions Capital

Ally Bridge Group

Sequoia Capital China

Blue Pool Capital

Genuity Science

Hillhouse Capital Group

China Merchants Securities

Canada Pension Plan Investment Board

Huangpu River Capital

PSP Investments

Illumina

GRAIL

GRAIL has been recognized on Fortune's 2023 #ChangeTheWorld list, as one of 50 companies driving positive social impact. 

This accomplishment is only possible due to the steadfast dedication of our employees, who are working together every day to redefine the status quo of cancer detection. Learn more: https://bit.ly/3ZB1KDu

This week GRAILers gathered to celebrate the upcoming #LunarNewYear. Best wishes and good fortune to all in the Year of the Dragon! 
#DiversityAndInclusion  

From addressing health disparities to advancing the science of cancer genomics, multi-cancer early detection has implications for many aspects of #cancer screening and care. We’re exploring the impacts of this technology on our podcast, The Cancer SIGNAL.

Subscribe here for new monthly episodes: https://bit.ly/42x1y9v

We’re excited to announce the name change of BIG (Black & Brown Influencers at GRAIL) in time for #BlackHistoryMonth! Anwell Wilbekin and Rich S.T Gilliam, co-leaders of BIG, unveil the new identity and outline upcoming events. We've curated insightful panel discussions on influence and health equity, along with a creative virtual paint night. Stay tuned for a month filled with celebration and empowerment at GRAIL! #DiversityAndInclusion #GRAILproud 

Proactive tools, like multi-cancer early detection tests, are helping people take more control of their health – but there’s more work to be done to help #CloseTheCareGap.

Ahead of #WorldCancerDay, we’re revisiting our podcast interview with Dr. Gary Puckrein, President and CEO of the National Minority Quality Forum, as he discusses how we can address barriers to equity in cancer screening. Hear more in this episode of #TheCancerSignal: https://bit.ly/49eqd5z 

Find us on all major podcast platforms:  
Apple: https://apple.co/3W0dso3  
Spotify: https://spoti.fi/3Kbe9Z8 
Google: https://bit.ly/3Fmp9j4 

	Jan '22	Dec '22	Dec '23
account payables	17.65M -	17.48M 0.94%	19.67M 12.54%
accumulated other comprehensive income loss	315.00K -	894K 183.81%	1.07M 19.24%
cash and cash equivalents	221.16M -	241.60M 9.24%	97.29M 59.73%
cash and short term investments	221.16M -	241.60M 9.24%	97.29M 59.73%
common stock	10.34B -	10.96B 5.94%	11.42B 4.25%
deferred revenue
deferred revenue non current
deferrred tax liabilities non current		735.19M -	676.03M 8.05%
goodwill	6.20B -	1.50B 75.84%	888.94M 40.63%
goodwill and intangible assets	9.27B -	4.43B 52.19%	3.58B 19.33%
intangible assets	3.07B -	2.94B 4.50%	2.69B 8.46%
inventory		19.75M -	21.70M 9.82%
long term debt	96.75M -	82.67M 14.55%	69.60M 15.82%
long term investments		4.53M -	4.22M 6.77%
net debt	-124.41M -	-145.59M 17.02%	-12.88M 91.15%
net receivables	6.88M -	18.61M 170.49%	22.35M 20.08%
other assets
other current assets	14.70M -	15.67M 6.61%	14.73M 5.98%
other current liabilities	80.24M -	104.13M 29.77%	129.13M 24.01%
other liabilities
other non current assets	7.10M -	6.14M 13.50%	7.98M 30.03%
other non current liabilities	112.76M -	3.13M 97.22%	1.50M 52.20%
othertotal stockholders equity	1 -
preferred stock
property plant equipment net	216.37M -	198.72M 8.15%	169.38M 14.77%
retained earnings	-911.54M -	-6.31B 592.30%	-7.78B 23.23%
short term debt		13.34M -	14.81M 11.05%
short term investments
tax assets		664.12M -	643.11M 3.16%
tax payables
total assets	9.74B -	5.60B 42.47%	4.56B 18.66%
total current assets	242.73M -	295.63M 21.79%	156.06M 47.21%
total current liabilities	97.89M -	134.94M 37.85%	163.61M 21.25%
total debt	96.75M -	96.01M 0.76%	84.41M 12.09%
total investments		4.53M -	4.22M 6.77%
total liabilities	307.40M -	955.94M 210.98%	910.74M 4.73%
total liabilities and stockholders equity	9.74B -	5.60B 42.47%	4.56B 18.66%
total non current assets	9.50B -	5.31B 44.11%	4.40B 17.07%
total non current liabilities	209.51M -	821M 291.87%	747.13M 9.00%
total stockholders equity	9.43B -	4.65B 50.73%	3.65B 21.52%

GRAL

COM:GRAIL

GRAIL

Last Close

16.38

22/11 21:00

Market Cap

431.58M

Beta: -

Volume Today

526.34K

Avg: -

Preview